254 related articles for article (PubMed ID: 3537447)
1. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.
Bariety J; Hinglais N; Bhakdi S; Mandet C; Rouchon M; Kazatchkine MD
Clin Exp Immunol; 1989 Jan; 75(1):76-81. PubMed ID: 2467771
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of C3 cleavage fragments, factor H, and the C5b-9 terminal complex of complement in de novo membranous glomerulonephritis occurring in patients with renal transplant.
Cosyns JP; Kazatchkine MD; Bhakdi S; Mandet C; Grossetete J; Hinglais N; Bariety J
Clin Nephrol; 1986 Oct; 26(4):203-8. PubMed ID: 2946502
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor.
Okada M; Yoshioka K; Takemura T; Akano N; Aya N; Murakami K; Maki S
Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):367-73. PubMed ID: 8322453
[TBL] [Abstract][Full Text] [Related]
5. Localization of the membrane attack complex (MAC) in experimental immune complex glomerulonephritis.
Koffler D; Biesecker G; Noble B; Andres GA; Martinez-Hernandez A
J Exp Med; 1983 Jun; 157(6):1885-905. PubMed ID: 6343549
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis.
Niculescu F; Rus HG; Vlaicu R
Atherosclerosis; 1987 May; 65(1-2):1-11. PubMed ID: 2955791
[TBL] [Abstract][Full Text] [Related]
7. [Presence of the terminal complement activation complex (C5b-9) on cell remnants within connective matrices of normal human kidney].
Bariety J; Hinglais N; Bhakdi S; Kazatchkine M
C R Seances Acad Sci III; 1983; 297(9):459-61. PubMed ID: 6421463
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of the terminal C5b-9 complement complex in children with glomerular diseases.
Rus HG; Niculescu F; Nanulescu M; Cristea A; Florescu P
Clin Exp Immunol; 1986 Jul; 65(1):66-72. PubMed ID: 3539428
[TBL] [Abstract][Full Text] [Related]
9. C5b-9 deposition in children with glomerular diseases.
Nanulescu M; Rus HG; Niculescu F; Cristea A; Florescu P
Med Interne; 1987; 25(2):99-104. PubMed ID: 3303285
[TBL] [Abstract][Full Text] [Related]
10. Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque.
Rus HG; Niculescu F; Constantinescu E; Cristea A; Vlaicu R
Atherosclerosis; 1986 Jul; 61(1):35-42. PubMed ID: 3524587
[TBL] [Abstract][Full Text] [Related]
11. [Vitronectin in children with renal disease--1. Immunofluorescence study of vitronectin and C5b-9 in childhood IgA nephropathy].
Takahashi T; Inaba S; Okada T
Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):213-23. PubMed ID: 7541480
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical studies of vitronectin, C5b-9, and vitronectin receptor in membranous nephropathy.
Ogawa T; Yorioka N; Yamakido M
Nephron; 1994; 68(1):87-96. PubMed ID: 7527506
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of the membrane attack complex of complement in IgA nephropathy.
Miyamoto H; Yoshioka K; Takemura T; Akano N; Maki S
Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):77-86. PubMed ID: 3131958
[TBL] [Abstract][Full Text] [Related]
14. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat.
Schulze M; Baker PJ; Perkinson DT; Johnson RJ; Ochi RF; Stahl RA; Couser WG
Kidney Int; 1989 Jan; 35(1):60-8. PubMed ID: 2651753
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis.
Pruchno CJ; Burns MM; Schulze M; Johnson RJ; Baker PJ; Alpers CE; Couser WG
Am J Pathol; 1991 Jan; 138(1):203-11. PubMed ID: 1987766
[TBL] [Abstract][Full Text] [Related]
16. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes.
Ozawa T; Pluss R; Lacher J; Boedecker E; Guggenheim S; Hammond W; McIntosh R
Q J Med; 1975 Oct; 44(176):523-41. PubMed ID: 53850
[TBL] [Abstract][Full Text] [Related]
17. Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue.
Falk RJ; Podack E; Dalmasso AP; Jennette JC
Am J Pathol; 1987 Apr; 127(1):182-90. PubMed ID: 2952015
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of C3d deposits in membranous nephropathy.
Doi T; Kanatsu K; Nagai H; Suehiro F; Kuwahara T; Hamashima Y
Nephron; 1984; 37(4):232-5. PubMed ID: 6379483
[TBL] [Abstract][Full Text] [Related]
19. Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis.
Schulze M; Pruchno CJ; Burns M; Baker PJ; Johnson RJ; Couser WG
Am J Pathol; 1993 Jan; 142(1):179-87. PubMed ID: 7678717
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous vascular deposition of C5b-9 and its role as a diagnostic adjunct in the setting of diabetes mellitus and porphyria cutanea tarda.
Vasil KE; Magro CM
J Am Acad Dermatol; 2007 Jan; 56(1):96-104. PubMed ID: 17190626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
